Alimentary Pharmacology and Therapeutics
Displaying 1 - 19 of 19
Szilcz, M., Wastesson, J. W., Bergman, D., Johnell, K., & Ludvigsson, J. F. (2025). Antibiotic Use and Risk of Microscopic Colitis in Older Adults: A Nationwide Self‐Controlled Case Series Study. Alimentary Pharmacology & Therapeutics. Portico. https://doi.org/10.1111/apt.70028
Publication Date
Columbia Affiliation
View
Albaneze, N., Cotton, C. C., Anderson, C., Katzka, D. A., & Dellon, E. S. (2024). No Association Between Eosinophilic Oesophagitis and Oesophageal Cancer in US Adults: A Case–Control Study. Alimentary Pharmacology & Therapeutics, 61(2), 363–368. Portico. https://doi.org/10.1111/apt.18431
Publication Date
Columbia Affiliation
Hu, K., Sedki, M., Kwong, A., Kesselman, A., Kolli, K. P., Morelli, G., Spengler, E., Said, A., Lai, J., Desai, A., Paul, S., Frenette, C., Fallon, M., German, M., Verna, E., Boike, J., Gregory, D., Thornburg, B., … VanWagner, L. (2024). Portal Hypertensive Gastropathy and MELD‐Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics. Portico. https://doi.org/10.1111/apt.18362
Publication Date
Columbia Affiliation
Mårild, K., Söderling, J., Axelrad, J., Halfvarson, J., Forss, A., Michaëlsson, K., Olén, O., & Ludvigsson, J. F. (2024). A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk. Alimentary Pharmacology & Therapeutics, 60(11–12), 1549–1560. Portico. https://doi.org/10.1111/apt.18275
Publication Date
Columbia Affiliation
Kilgore, A., & Khlevner, J. (2024). Functional Constipation: Pathophysiology, evaluation, and management. Alimentary Pharmacology & Therapeutics, 60(S1). Portico. https://doi.org/10.1111/apt.17852
Publication Date
Columbia Affiliation
Loomba, R., Clark, G., Teckman, J., Ajmera, V., Behling, C., Brantly, M., Brenner, D., D’Armiento, J., Fried, M. W., Iyer, J. S., Mandorfer, M., Rockey, D. C., Tincopa, M., Vuppalanchi, R., Younossi, Z., Krag, A., Turner, A. M., & Strnad, P. (2024). Review article: New developments in biomarkers and clinical drug development in alpha‐1 antitrypsin deficiency‐related liver disease. Alimentary Pharmacology & Therapeutics, 59(10), 1183–1195. Portico. https://doi.org/10.1111/apt.17967
Publication Date
Columbia Affiliation
View
Ricciuto, A., Liu, K., El‐Matary, W., Amin, M., Amir, A. Z., Aumar, M., Auth, M., Di Guglielmo, M. D., Druve Tavares Fagundes, E., Rodrigues Ferreira, A., Furuya, K. N., Gupta, N., Guthery, S., Horslen, S. P., Jensen, K., Kamath, B. M., Kerkar, N., Koot, B. G. P., … Laborda, T. J. (2024). Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium. Alimentary Pharmacology & Therapeutics, 59(10), 1236–1247. Portico. https://doi.org/10.1111/apt.17936
Publication Date
Columbia Affiliation
Eriksson, C., Sun, J., Bryder, M., Bröms, G., Everhov, Å. H., Forss, A., Jernberg, T., Ludvigsson, J. F., & Olén, O. (2024). Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide Cohort Study. Alimentary Pharmacology & Therapeutics, 59(9), 1122–1133. Portico. https://doi.org/10.1111/apt.17932
Publication Date
Columbia Affiliation
Staller, K., Olén, O., Söderling, J., Roelstraete, B., Törnblom, H., Kuo, B., Nguyen, L. H., & Ludvigsson, J. F. (2023). Antibiotic use as a risk factor for irritable bowel syndrome: Results from a nationwide, case–control study. Alimentary Pharmacology & Therapeutics, 58(11–12), 1175–1184. Portico. https://doi.org/10.1111/apt.17736
Publication Date
Columbia Affiliation
Bergman, D., Roelstraete, B., Sun, J., Ebrahimi, F., Askling, J., & Ludvigsson, J. F. (2023). Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population‐based matched cohort study. Alimentary Pharmacology & Therapeutics, 58(10), 1028–1040. Portico. https://doi.org/10.1111/apt.17708
Publication Date
Columbia Affiliation
Hirano, I., Dellon, E. S., Gupta, S. K., Katzka, D. A., Collins, M. H., Wojtowicz, A. M., Terreri, B., Zhang, W., Boules, M., Bhatia, S., & Desai, N. K. (2023). Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials. Alimentary Pharmacology & Therapeutics, 57(10), 1117–1130. Portico. https://doi.org/10.1111/apt.17430
Publication Date
Columbia Affiliation
Andrews, C. N., Rehak, R., Woo, M., Walker, I., Ma, C., Forbes, N., Rittenbach, K., Hathaway, J., Wilsack, L., Liu, A., Nasser, Y., & Sharkey, K. A. (2022). Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence. Alimentary Pharmacology & Therapeutics, 56(11–12), 1532–1542. Portico. https://doi.org/10.1111/apt.17265
Publication Date
Columbia Affiliation
Yadlapati, R., Gawron, A. J., Gyawali, C. P., Chen, J., Clarke, J., Fass, R., Jain, A., Lynch, K., Khan, A., Katz, P. O., Katzka, D. A., Richter, J., Schnoll‐Sussman, F., Spechler, S. J., Vaezi, M. F., Vela, M., & Pandolfino, J. E. (2022). Clinical role of ambulatory reflux monitoring in PPI non‐responders: recommendation statements. Alimentary Pharmacology & Therapeutics, 56(8), 1274–1283. Portico. https://doi.org/10.1111/apt.17180
Publication Date
Columbia Affiliation
View
Everhov, Å. H., Erichsen, R., Järås, J., Pedersen, L., Halfvarson, J., Askling, J., Ekbom, A., Ludvigsson, J. F., Sørensen, H. T., & Olén, O. (2022). Colorectal cancer in elderly‐onset inflammatory bowel disease: a 1969–2017 Scandinavian register‐based cohort study. Alimentary Pharmacology & Therapeutics, 56(7), 1168–1182. Portico. https://doi.org/10.1111/apt.17175
Publication Date
Columbia Affiliation
Faye, A. S., Lee, K. E., Dodson, J., Chodosh, J., Hudesman, D., Remzi, F., Wright, J. D., Friedman, A. M., Shaukat, A., & Wen, T. (2022). Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis. Alimentary Pharmacology & Therapeutics, 56(7), 1157–1167. Portico. https://doi.org/10.1111/apt.17162
Publication Date
Columbia Affiliation
Halfvarson, J., Ludvigsson, J. F., Bresso, F., Askling, J., Sachs, M. C., & Olén, O. (2022). Age determines the risk of familial inflammatory bowel disease—A nationwide study. Alimentary Pharmacology & Therapeutics, 56(3), 491–500. Portico. https://doi.org/10.1111/apt.16938
Publication Date
Columbia Affiliation
Lee, A. R. (2022). Review article: Dietary management of coeliac disease. Alimentary Pharmacology & Therapeutics, 56(S1). Portico. https://doi.org/10.1111/apt.16974
Publication Date
Columbia Affiliation
View
Odewole, M., Sen, A., Okoruwa, E., Lieber, S. R., Cotter, T. G., Nguyen, A. D., Mufti, A., Singal, A. G., & Rich, N. E. (2022). Systematic review with meta‐analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography. Alimentary Pharmacology & Therapeutics, 55(9), 1088–1098. Portico. https://doi.org/10.1111/apt.16860
Publication Date
Columbia Affiliation
View
Forss, A., Clements, M., Bergman, D., Roelstraete, B., Kaplan, G. G., Myrelid, P., Halfvarson, J., Olén, O., & Ludvigsson, J. F. (2021). A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Alimentary Pharmacology & Therapeutics, 55(6), 691–699. Portico. https://doi.org/10.1111/apt.16735
Publication Date
Columbia Affiliation
View